In 2010, China's pharmaceutical sector attracted $1 billion VC investment and launched 33 IPOs. China is the world's number two pharmacy market, but is forecast to rise to $100 billion in 2015.

Figures show that 25 percent of all healthcare products are estimated to be temperature-sensitive, and by 2016 more than half of the top 50 best-selling drugs will require cold chain transportation.

Eyeing the prosperous outlook, FedEx is working on connecting medical products to people around the world, through temperature-controlled packaging and fleets, and customized delivery services, said Chan.

In 2012, the company introduced a variety of cold chain shipping solutions that help connect manufacturers in innovative ways with more markets across industries, including thermal blankets, a cold shipping package option and deep frozen shipping solution.

"FedEx will continue to focus on some key vertical markets such as healthcare," he said.

FedEx was one of the first express cargo companies operating between the two regions, and in the past years FedEx has dramatically enhanced its services between China and Europe to meet increased customer demand, as China has become Europe's fastest-growing export market and second largest trading partner, and China's exports to the EU hit $4 trillion in 2013, according to the Chinese General Administration of Customs.

FedEx is committed to offering customers a competitive edge by strengthening its connection between China and Europe, Chan said.

FedEx launched its express air cargo, the industry's first express direct flight from the Chinese mainland to Europe in March 2005. In addition, FedEx also links Asia and Europe with direct flights.

"FedEx added two Boeing 777F flights from Asia to Europe, including our first direct flight from the FedEx Asia-Pacific Hub in Guangzhou to Europe in 2012," said Chan.

"For instance, when it comes to shipping low-value items, tracking and short transit times are not a priority; customers want reliable and cost-effective transport solutions."

zhengxin@chinadaily.com.cn